Rimtoregtide features a tailored peptide architecture used in advanced receptor and signaling research. Distinct residue placement enables modeling of molecular recognition within regulatory pathways. Its physicochemical properties support analyses of conformational dynamics in solution. Investigators employ the compound in binding assays, sequence optimization, and bioactive peptide design.
CAT No: R2320
CAS No:2251722-35-5
Synonyms/Alias:Rimtoregtide;2251722-35-5;Rimtoregtide [INN];UNII-NYA2G8ZG88;NYA2G8ZG88;L-Serine, N-acetyl-L-isoleucylglycyl-L-leucyl-L-histidyl-L-alpha-aspartyl-L-prolyl-L-seryl-L-histidylglycyl-L-threonyl-L-leucyl-L-prolyl-L-alanylglycyl-;HTD4010;GLXC-27906;HY-P3377;DA-57452;MS-32190;CS-0376567;
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.